ClinicalTrials.Veeva

Menu

Mood and Cognitive Outcome After Heart Transplantation (the MOODHEART Study)

University of Oslo (UIO) logo

University of Oslo (UIO)

Status

Completed

Conditions

Cognition Disorders
Psychiatric Diagnosis

Study type

Observational

Funder types

Other

Identifiers

NCT02035865
REK sør-øst 2013/1260

Details and patient eligibility

About

The investigators aim at characterizing neuropsychiatric consequences of heart transplantation (HTX) and at assessing the impact of depressive symptoms after HTX on mortality and cardiac allograft vasculopathy (CAV).

Enrollment

74 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participant in one of two former studies and heart transplanted at the time of inclusion into this former study

Exclusion criteria

  • Cognitively not capable to consent to participation and/or
  • Insufficient fluent in the Norwegian language to complete both psychiatric and neuropsychological assessment

Trial design

74 participants in 2 patient groups

Participants from former study 1
Description:
Surviving participants from a former study called 'Psykosomale faktorer hos pasienter med hjertesvikt og hos hjertetransplanterte'
Participants from former study 2
Description:
Surviving participants, included at the Norwegian centre, from a study called 'Scandinavian Heart Transplant Everolimus De Novo Study with Early Calcineurin Inhibitor Avoidance (SCHEDULE)' (NCT01266148)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems